Pediatrics (System-Integrated)

Turner syndrome: features and management

Clinical Overview and When to Suspect Turner Syndrome

— Karyotypes: 45,X (~45%), 45,X/46,XX mosaicism (~15–25%), isochromosome Xq (~15%), ring X, 45,X/46,XY (~5–10%, gonadoblastoma risk)

— Incidence ~1 in 2,000–2,500 live female births; most 45,X conceptuses miscarry

— Prenatal: cystic hygroma, increased nuchal translucency, fetal hydrops, coarctation/left-sided heart lesion, horseshoe kidney, or abnormal cell-free DNA showing monosomy X

— Neonatal: lymphedema of hands/feet, redundant nuchal skin, low birth weight, left-sided cardiac lesion, feeding difficulty

— Childhood: short stature falling off the growth curve after age 3, recurrent otitis media, chronic serous otitis, learning differences in visuospatial/math

— Adolescent: delayed puberty, primary amenorrhea, or arrested puberty with elevated FSH; absent thelarche by 13

— Adult: infertility workup, premature ovarian insufficiency, unexplained osteoporosis, aortic dissection in a short woman

Definition: Turner syndrome (TS) is a sex chromosome disorder in phenotypic females caused by complete or partial absence of the second X chromosome, with or without cell-line mosaicism.

When to suspect across the lifespan (suspicion drives the karyotype order):

Phenotype is highly variable — mosaic patients can look entirely normal except for short stature or infertility. Do not require classic stigmata to test.

Step 3 management: Order a peripheral blood karyotype (≥30 cells) in any phenotypic female with otherwise unexplained short stature, primary or secondary amenorrhea with elevated gonadotropins, or a left-sided congenital heart lesion. If clinical suspicion remains high after a normal blood karyotype, send a second tissue (buccal or skin fibroblast) karyotype to detect low-level mosaicism.

Board pearl: Two findings should reflexively trigger TS testing on the exam — short stature with delayed puberty and coarctation of the aorta in a girl.

Presentation Patterns and Key History

— Congenital lymphedema of dorsa of hands/feet (often the first clue in the newborn nursery)

— Webbed neck from in-utero cystic hygroma resolution → redundant nuchal skin

— Feeding difficulty, failure to thrive, low-set ears, narrow high-arched palate

— Murmur or femoral pulse deficit → coarctation or bicuspid aortic valve

— Progressive short stature is the single most common feature (>95%); growth velocity drops by age 3 and the child falls off her curve

— Chronic otitis media and conductive hearing loss from eustachian tube dysfunction; later sensorineural loss develops

— Learning profile: normal verbal IQ, weak nonverbal/visuospatial/math (NLD-like profile); social cognition difficulties

— Strabismus, ptosis, amblyopia

— Absent or arrested puberty (~90% have ovarian failure); primary amenorrhea with elevated FSH/LH

— Spontaneous puberty in ~30% (mostly mosaics), but only ~2–5% achieve spontaneous pregnancy

— Short stature persists; final untreated adult height ~143 cm (~20 cm below target)

— Infertility / premature ovarian insufficiency

— Unexplained hypertension in a short woman

— Aortic dissection in a young woman — always think TS or Marfan/Loeys-Dietz

— Osteoporotic fracture, autoimmune thyroid disease, celiac disease

— Prenatal U/S findings, NIPT results, birth lymphedema

— Growth chart trajectory (request prior records — CCS habit)

— Pubertal milestones, menstrual history, fertility history

— Hearing, vision, school performance, prior cardiac/renal imaging

Infancy presentation cluster:

Childhood presentation cluster:

Adolescent presentation cluster:

Adult presentation cluster:

Key history to elicit:

Key distinction: Noonan syndrome shares webbed neck, short stature, lymphedema, and right-sided cardiac lesions (pulmonary stenosis, HCM) — but karyotype is normal and inheritance is autosomal dominant (PTPN11). If the karyotype is normal in a "Turner-like" boy or girl, think Noonan.

Physical Exam Findings and Hemodynamic Assessment

— Low posterior hairline, webbed neck (pterygium colli), short neck

— Low-set posteriorly rotated ears, prominent ears, narrow high-arched palate, micrognathia, dental crowding

— Epicanthal folds, ptosis, hypertelorism, downslanting palpebral fissures

— Shield chest with widely spaced (hypoplastic, inverted) nipples

— Four-extremity blood pressures and simultaneous brachial–femoral pulse palpation — radiofemoral delay or arm-leg BP gradient >20 mmHg suggests coarctation

— Systolic ejection click and crescendo-decrescendo murmur at RUSB → bicuspid aortic valve (~30%)

— Continuous interscapular murmur → coarctation collaterals

— Tall, thin, hypertensive young woman → screen for aortic root dilation

— Cubitus valgus (increased carrying angle), Madelung deformity of the wrist

— Short fourth metacarpal (positive metacarpal sign — knuckle 4 sits below the line of knuckles 3 and 5)

— Genu valgum, scoliosis, kyphosis

— Hyperconvex/dysplastic nails, multiple pigmented nevi

— Persistent lymphedema of hands and feet

— Keloid formation; increased nevi; vitiligo, alopecia areata (autoimmune overlap)

— Streak gonads, infantile uterus on imaging

— Tanner stage typically prepubertal at presentation

Head and neck:

Chest and cardiovascular (highest-yield exam):

Extremities and skeleton:

Skin and lymphatics:

Genitourinary:

Abdomen: palpable mass uncommon; horseshoe kidney usually silent

Neuro/developmental: normal gross motor; nonverbal learning profile; social anxiety

CCS pearl: On the CCS, in any short adolescent girl with delayed puberty, order four-extremity BPs, brachial-femoral pulse check, and an echocardiogram on day 1. Missing a coarctation or aortic root dilation is the costly error.

Board pearl: Short 4th metacarpal + cubitus valgus + webbed neck = Turner until karyotype proven otherwise.

Diagnostic Workup — Initial Labs, Imaging, and Confirmation

— Peripheral blood karyotype, ≥30 metaphase cells — counts more cells than the standard 20 to detect mosaicism

— If clinical suspicion remains high despite a normal blood karyotype → second tissue karyotype (buccal mucosa or skin fibroblast) or FISH/chromosomal microarray for cryptic mosaicism

— If any Y-chromosome material is identified (45,X/46,XY; marker chromosome) → prophylactic gonadectomy for gonadoblastoma risk (~15–30%)

— TSH and anti-TPO antibodies — Hashimoto thyroiditis in ~30%

— Tissue transglutaminase IgA + total IgA — celiac disease in ~5–8%

— CBC, CMP (LFTs commonly elevated; baseline renal function)

— Fasting glucose and HbA1c (insulin resistance, T2DM risk)

— Lipid panel

— FSH, LH, estradiol, AMH — assess ovarian reserve; AMH helps predict spontaneous puberty/fertility

— 25-OH vitamin D

— IGF-1, IGFBP-3 before initiating growth hormone

— Transthoracic echocardiogram — bicuspid valve, coarctation, aortic root size (indexed to BSA → ASI)

— Cardiac MRI at transition to adult care or by age 12 if able to cooperate without sedation — detects partial anomalous pulmonary venous return, elongated transverse arch, aortic dimensions missed on echo

— Renal ultrasound — horseshoe kidney, duplicated collecting system, malrotation (~30–40%)

— Audiology (otoacoustic emissions/audiometry); ENT eval

— DXA at appropriate age (after estrogen replacement initiated/in adulthood)

— Ophthalmology referral

Confirmatory test (the only test that "makes the diagnosis"):

At-diagnosis baseline labs (all patients):

At-diagnosis baseline imaging:

Step 3 management: Any newly diagnosed TS patient gets a "Turner bundle" on day 1 — karyotype confirmation, TSH, TTG-IgA, CMP, lipids, A1c, FSH/LH/estradiol/AMH, echo, renal US, audiology. Memorize this bundle; it appears as a multi-select CCS order set.

Board pearl: Echo can miss aortic arch anomalies — cardiac MRI is mandatory at least once.

Diagnostic Workup — Advanced and Confirmatory Studies

— Request karyotype on a second tissue (buccal smear or skin fibroblasts) — detects low-level somatic mosaicism

— Add FISH probes for X and Y centromeres to screen for occult Y material, particularly if virilization, clitoromegaly, or a marker chromosome is present

— Chromosomal microarray (CMA) identifies structural X abnormalities (ring X, isochromosome Xq, deletions) and submicroscopic Y material

— NIPT can suggest monosomy X but has a high false-positive rate (placental mosaicism, confined placental mosaicism, maternal mosaicism) → confirm with diagnostic amniocentesis before counseling

— Ultrasound findings prompting karyotype: cystic hygroma, nuchal edema, hydrops, coarctation, horseshoe kidney, short femur

— CMR with aortic dimensions indexed to BSA (aortic size index, ASI): ASI >2.0 cm/m² = elevated dissection risk; ASI >2.5 cm/m² = high risk → consider prophylactic repair

— In adults, repeat CMR every 5–10 years if baseline normal; annually if root dilated or other risk factors

— AMH as best predictor of residual ovarian function; antral follicle count on pelvic US

— Consider oocyte cryopreservation in mosaic patients with detectable AMH and spontaneous puberty — refer to reproductive endocrinology early, ideally peripubertal

— DXA in adulthood; correct estrogen deficiency first before interpreting Z-scores (otherwise overcalls osteoporosis)

— Persistently elevated transaminases are common (nodular regenerative hyperplasia); imaging if >2× ULN or progressive; avoid reflex hepatology biopsy

— Serial audiograms every 3–5 years; progressive mid-frequency sensorineural loss is characteristic

When the blood karyotype is normal but suspicion remains high:

Prenatal diagnosis nuances:

Advanced cardiac imaging:

Ovarian and fertility evaluation:

Bone health:

Metabolic and hepatic:

Hearing:

Key distinction: In 45,X/46,XY mosaicism, the gonad is at risk for gonadoblastoma → dysgerminoma. Prophylactic bilateral gonadectomy is recommended at the time of diagnosis. Streak gonads in pure 45,X without Y material do not require removal.

Board pearl: A "marker chromosome" on karyotype → always FISH it for Y-material before deciding on gonadectomy.

Risk Stratification and First-Line Management Logic

— Pediatric endocrinology (growth, puberty, thyroid, bone)

— Cardiology (lifelong)

— Gynecology/reproductive endocrinology

— ENT/audiology, ophthalmology

— Psychology/neuropsych, genetics counseling

— Primary care as the longitudinal "home"

— Cardiovascular risk: bicuspid valve, coarctation, aortic root z-score/ASI, hypertension → drives surveillance interval

— Endocrine risk: growth velocity, bone age, gonadotropins, AMH → drives GH/estrogen timing

— Autoimmune risk: baseline TSH/TPO, TTG-IgA → annual rescreening

— Metabolic risk: A1c, lipids, BMI → counsel on weight, exercise

— Psychosocial/learning: neuropsych at school entry and again at transitions

— (1) Growth: initiate recombinant human growth hormone (rhGH) when height drops below the normal female curve or growth velocity slows, often by age 4–6 (sometimes earlier). Goal: maximize adult height before estrogen-induced epiphyseal fusion.

— (2) Puberty induction: start low-dose transdermal estradiol at ~11–12 years if no spontaneous puberty; titrate up over 2–3 years; add cyclic progesterone after 2 years of estrogen or once breakthrough bleeding occurs

— (3) Cardiovascular and organ surveillance: lifelong

— Continue estrogen-progestin replacement until average age of menopause (~50)

— Cardiac imaging surveillance, BP control, bone density, lipid/glucose monitoring

— Fertility planning — donor oocyte IVF is the most common path; pregnancy is high-risk

Multidisciplinary team is the management backbone:

Risk stratification domains at diagnosis:

Three pillars of pediatric management:

Adult transition pillars:

Step 3 management: When you "stage" a newly diagnosed TS patient on the exam, your first three orders are karyotype confirmation, echocardiogram, and endocrine baseline panel (TSH, FSH, IGF-1, A1c, lipids) — then refer to multidisciplinary team. Do not start GH before confirming karyotype and obtaining baseline IGF-1 and thyroid function.

Board pearl: GH does not treat the underlying ovarian failure — you still need estrogen for puberty and bone health.

Pharmacotherapy — Growth Hormone and Hormone Replacement

— Indication: FDA-approved for short stature in TS regardless of GH deficiency

— Timing: start when height drops below 5th percentile or growth velocity declines, often age 4–6, sometimes as young as age 9 months–2 years if already short

— Dose: ~0.375 mg/kg/week divided into daily SC injections (higher than for classic GH deficiency)

— Add oxandrolone (low-dose anabolic steroid, 0.03–0.05 mg/kg/day) in girls >9–10 years with very short predicted adult height — modest additive height gain

— Monitor: height velocity every 4–6 months, IGF-1 (keep within age-appropriate range, avoid >+2 SD), TSH, fasting glucose, scoliosis exam, slipped capital femoral epiphysis screen, ophthalmologic exam (pseudotumor cerebri)

— Stop GH when bone age >14 and height velocity <2 cm/year, or near-final height achieved

— Contraindications: active malignancy, severe scoliosis progression, severe obesity with sleep apnea unaddressed, proliferative diabetic retinopathy

— First-line: transdermal 17β-estradiol patch (more physiologic, avoids first-pass hepatic effects, lower VTE risk)

— Start low dose (~6.25 µg/day patch or equivalent) at ~11–12 years; titrate every 6 months over 2–3 years to adult replacement (~100 µg/day)

— Goal: mimic normal pubertal tempo — do not start at full adult dose (compromises final height and breast development)

— Oral estradiol is acceptable if patch not tolerated

— Add cyclic micronized progesterone (or medroxyprogesterone) after 2 years of estrogen or after breakthrough bleeding — protects endometrium

— Continue combined HRT until ~age 50 (average menopause)

— Levothyroxine for hypothyroidism (common comorbidity)

— Antihypertensives: ACE inhibitors or ARBs preferred if aortopathy/proteinuria; beta-blockers especially with aortic root dilation

— Bisphosphonates generally not first-line in young adults — optimize estrogen, vitamin D, calcium first

Recombinant human growth hormone (rhGH, somatropin):

Estrogen replacement (puberty induction):

Progesterone:

Adjunctive pharmacotherapy:

Step 3 management: Do not delay puberty induction to "buy more height with GH" — current guidelines say start estrogen by age 12 even if still on GH; combined therapy maximizes both height and psychosocial outcomes.

Board pearl: Transdermal estradiol > oral for TS — better aortic, hepatic, and VTE profile.

Procedures and Invasive Management

— Coarctation repair — surgical end-to-end anastomosis in infants; balloon angioplasty ± stenting in older children/adults. Lifelong surveillance for re-coarctation, aneurysm at repair site, and ascending aortic dilation

— Bicuspid aortic valve — surveillance for stenosis/regurgitation; valve replacement (mechanical vs. bioprosthetic) when symptomatic or per standard valve criteria; Ross procedure occasionally in young patients

— Aortic root replacement thresholds in TS are lower than general population:

— ASI >2.5 cm/m², or >2.0 cm/m² with risk factors (bicuspid valve, coarctation, hypertension) → consider elective repair

— Acute dissection → emergency surgery (Stanford A) or medical management ± TEVAR (Stanford B)

— Bilateral prophylactic gonadectomy at time of diagnosis for 45,X/46,XY or marker chromosome with Y-FISH positive — gonadoblastoma can transform to dysgerminoma

— Laparoscopic approach standard

— Oocyte cryopreservation in adolescents with detectable AMH/antral follicles — refer before ovarian reserve is exhausted

— Donor oocyte IVF is the most common path to pregnancy; single-embryo transfer to reduce cardiovascular load

— Preconception cardiac evaluation is mandatory — echo + CMR within 2 years, BP optimization

— Tympanostomy tubes for chronic serous OM

— Hearing aids for progressive sensorineural loss

— Scoliosis bracing/surgery as indicated; Madelung deformity correction occasionally

— Compression garments, manual lymphatic drainage; surgery rarely needed

Cardiovascular interventions:

Gonadectomy (Y-material present):

Fertility procedures:

ENT procedures:

Orthopedic procedures:

Lymphedema:

CCS pearl: On CCS, for any TS patient considering pregnancy, order preconception echocardiogram and cardiac MRI, BP optimization, MFM consult, and genetic counseling. Aortic dissection risk in pregnancy is ~2% in TS — the leading cause of maternal mortality in this population.

Board pearl: Pregnancy in TS with aortic root z-score >2 or ASI >2.0 is a relative contraindication — many experts consider it absolute if dilation progresses.

Special Populations — Adult, Elderly, and Organ Impairment

— Transition from pediatric to adult care at age 18–21 with a structured handoff document including karyotype, cardiac imaging history, HRT regimen, comorbidities

— Adult women with TS need lifelong cardiology, gynecology, endocrinology, and primary care follow-up

— Most TS cohorts have shortened life expectancy (~10–13 years reduced) driven by cardiovascular disease (ischemic heart disease, aortic dissection) and diabetes

— Earlier and more aggressive screening for CAD risk factors — strict BP, lipid, and glucose control

— DXA every 2–5 years; fracture risk elevated due to estrogen deficiency and skeletal dysplasia

— Continue estrogen-progestin replacement until ~age 50, then reassess risk/benefit as in natural menopause; do not abruptly stop HRT in TS earlier than the average menopause age — bone and cardiovascular harms

— Horseshoe kidney and collecting system anomalies predispose to recurrent UTIs, pyelonephritis, hydronephrosis, and rarely CKD

— Routine renal US at diagnosis; monitor creatinine, urinalysis at annual visits

— Dose-adjust renally cleared medications standardly

— Elevated transaminases occur in 30–80% of adults with TS — often nodular regenerative hyperplasia, NAFLD, or steatohepatitis

— Workup if persistent: U/S, hepatitis panel, autoimmune markers, iron studies; biopsy only if diagnostic uncertainty

— Oral estrogens worsen hepatic enzyme elevation → transdermal estradiol preferred

— TS has elevated risk for T2DM and insulin resistance; A1c yearly

— Type 1 DM also more common (autoimmune cluster)

— Manage per ADA — metformin first-line for T2DM; weight management critical

— Hashimoto thyroiditis (~30%), celiac disease (~5–8%), IBD, alopecia areata, vitiligo — annual TSH and periodic TTG-IgA screening

Adult/transition-of-care considerations:

Older adults with TS:

Renal impairment:

Hepatic considerations:

Diabetes and metabolic syndrome:

Autoimmune comorbidities:

Step 3 management: Persistently elevated LFTs in a TS patient → switch oral estrogen to transdermal before extensive hepatology workup; this often normalizes enzymes.

Board pearl: Aortic dissection in TS often occurs at smaller absolute diameters than in the general population — index to BSA.

Special Populations — Pregnancy and Pediatric Subgroups

— Spontaneous pregnancy: ~2–5% (mostly mosaic 45,X/46,XX); donor oocyte IVF is the typical route

— High-risk pregnancy — managed by MFM + adult congenital cardiology

— Cardiovascular risk: aortic dissection occurs in ~2% of TS pregnancies and is the leading cause of maternal death

— Preconception evaluation (mandatory):

— Echo + CMR within 2 years, aortic dimensions indexed

— BP optimization (<130/80)

— Treat thyroid disease, diabetes

— Genetic counseling — TS itself is rarely heritable but increased miscarriage, fetal aneuploidy risk

— Contraindications/relative contraindications to pregnancy:

— ASI >2.0–2.5 cm/m², prior aortic surgery, uncontrolled hypertension, severe valvular disease, significant CAD

— Antenatal management:

— Echo each trimester and 6 weeks postpartum

— Beta-blocker if aortic dilation

— Single-embryo transfer to limit cardiovascular strain

— Mode of delivery individualized; cesarean often favored if aortic dilation

— Postpartum surveillance — dissection risk extends weeks postpartum

— Infants with congenital lymphedema and webbed neck — early karyotype, echo, renal US

— Toddlers/preschool: monitor growth velocity quarterly; treat recurrent OM aggressively to prevent hearing loss and speech delay

— School-age: neuropsych eval — visuospatial and math learning differences common; IEP/504 plan; normal verbal IQ means difficulties are often overlooked

— Adolescents: address body image, short stature, pubertal delay psychologically; peer support groups; transition planning starting ~age 14

— Phenotype ranges from female TS to ambiguous genitalia to male with infertility

— Prophylactic gonadectomy for streak gonads in phenotypic females

— In phenotypic males, monitor scrotal gonads if present (some retained)

Pregnancy in Turner syndrome:

Pediatric subgroups:

Mosaic 45,X/46,XY patients:

CCS pearl: A TS adolescent considering pregnancy — your CCS clock items are echo, CMR, BP control, MFM referral, genetic counseling, single-embryo transfer counseling, and document risk discussion.

Board pearl: Donor oocyte + single-embryo transfer + cardiac clearance = standard TS pregnancy bundle.

Complications and Adverse Outcomes

— Bicuspid aortic valve → stenosis, regurgitation, endocarditis risk

— Coarctation → hypertension, re-coarctation, aneurysm

— Aortic root/ascending aortic dilation → dissection (Stanford A) — often at smaller dimensions than general population; pregnancy and hypertension amplify risk

— Hypertension (essential and renovascular) in ~50% of adults

— Premature coronary artery disease

— Prolonged QT interval — caution with QT-prolonging drugs

— Partial anomalous pulmonary venous return (~15%) — often missed on echo

— Ovarian failure / infertility

— Hashimoto thyroiditis, occasionally Graves

— T2DM, insulin resistance, dyslipidemia, NAFLD

— Osteoporosis — multifactorial (estrogen deficiency, vitamin D, intrinsic bone dysplasia)

— Celiac disease

— Inflammatory bowel disease

— Chronic hepatic enzyme elevation, nodular regenerative hyperplasia

— GI bleeding from intestinal telangiectasias / vascular malformations (uncommon but classic)

— Horseshoe kidney, duplicated systems, ectopic kidney → UTIs, hydronephrosis

— Recurrent OM, conductive then sensorineural hearing loss, cholesteatoma

— Strabismus, ptosis, amblyopia, red-green color deficiency, hyperopia

— Nonverbal learning disorder profile (visuospatial, math), executive dysfunction

— Anxiety, depression, social difficulties, body image issues

— ADHD overrepresented

— Gonadoblastoma → dysgerminoma in 45,X/46,XY or marker-chromosome-Y patients

— Overall malignancy risk in pure 45,X is not increased

— Aortic dissection, hypertensive disorders, preeclampsia, miscarriage

Cardiovascular (leading cause of mortality):

Endocrine and metabolic:

GI and hepatic:

Renal:

ENT:

Ophthalmologic:

Neurocognitive/psychosocial:

Malignancy (Y-material only):

Obstetric:

Key distinction: In TS, aortic dissection can occur at root diameters of 3.5–4 cm — much smaller than the 5.5 cm general threshold. Always index to BSA (ASI), not absolute diameter.

Board pearl: A short young woman with sudden tearing chest/back pain → think TS-associated aortic dissection.

When to Escalate Care — ICU, Consult, and Inpatient Triage

— Acute aortic dissection — sudden tearing chest or interscapular pain, pulse deficit, BP differential, widened mediastinum on CXR

— Immediate CT angiography of chest/abdomen/pelvis (or TEE if unstable)

— IV beta-blocker (esmolol or labetalol) to HR <60 and SBP <120 before vasodilators

— Type A → emergent cardiothoracic surgery; Type B → medical management ± TEVAR

— Acute aortic valve decompensation (severe AS or AR with HF) → cardiology/CT surgery

— Hypertensive emergency with end-organ damage → ICU IV antihypertensives

— Severe DKA / new T1DM presentation → ICU per pediatric protocols

— Pregnancy with chest pain or dyspnea → low threshold for echo, CT angiography, OB-MFM, and cardiology — assume dissection until ruled out

— Cardiology — any new murmur, aortic dimension increase, arrhythmia

— Cardiothoracic surgery — ASI approaching 2.0–2.5 cm/m² or rapid growth (>3 mm/year)

— Endocrinology — failure to grow on GH, thyroid storm, severe DKA

— Gynecology/REI — pubertal failure, fertility planning

— Genetics — at initial diagnosis and again at transition

— MFM — any TS patient contemplating or in pregnancy

— Pyelonephritis with horseshoe kidney

— Severe OM with mastoiditis

— Surgical procedures requiring perioperative cardiac monitoring (intubation can stress dilated aorta — anesthesia must know diagnosis)

— DKA, severe hypothyroidism/myxedema in undiagnosed cases

— Difficult airway — short neck, micrognathia, high-arched palate → alert anesthesia; consider video laryngoscopy, ENT backup

— Strict BP and HR control during intubation/extubation if any aortopathy

— Cervical spine evaluation if symptomatic (instability rare but reported)

Emergency escalation (call surgery / ICU now):

Urgent consultation:

Inpatient admission triggers:

Perioperative considerations (TS-specific):

CCS pearl: In a TS patient on the CCS presenting with chest or back pain, your first orders are two large-bore IVs, IV beta-blocker, CT angiography aorta, cardiothoracic surgery consult — not aspirin/heparin reflexively (could worsen dissection).

Board pearl: Aortic dissection beats ACS on the differential in a young TS woman with tearing pain — get the CTA.

Key Differentials — Same-Category (Short Stature/Pubertal Delay)

— Phenotype overlaps with TS (webbed neck, short stature, lymphedema, low-set ears, cubitus valgus)

— Normal karyotype; autosomal dominant; PTPN11, SOS1, RAF1 mutations

— Right-sided cardiac lesions: pulmonary valve stenosis, HCM (vs. left-sided in TS)

— Affects both sexes; bleeding diathesis common

— Swyer syndrome (46,XY complete gonadal dysgenesis): phenotypic female, normal height, primary amenorrhea, streak gonads, uterus present; high gonadoblastoma risk → gonadectomy

— 46,XX gonadal dysgenesis: primary amenorrhea, elevated FSH, normal stature, normal karyotype; FMR1 premutation, autoimmune

— Short stature, delayed bone age, delayed but normal puberty eventually; normal karyotype; family history common

— Both parents short, bone age = chronological age, normal puberty timing

— Short stature with low growth velocity, low IGF-1/IGFBP-3, abnormal GH stimulation testing; often normal proportions

— Acquired short stature, delayed bone age, weight gain, fatigue; TSH high — always rule out early

— Short stature with Madelung deformity (also seen in TS due to SHOX deletion on Xp)

— Mesomelic limb shortening, normal karyotype

— Disproportionate short stature, characteristic radiographs; molecular testing

— IBD, celiac, CKD, malnutrition — appropriate workup

— Autoimmune POI, FMR1 premutation, chemotherapy/radiation, galactosemia

— Normal stature distinguishes from TS

— Sex chromosome aneuploidy in males — tall stature, small testes, gynecomastia, infertility; opposite phenotype to TS

Noonan syndrome (RASopathy):

Other gonadal dysgenesis syndromes:

Constitutional growth delay:

Familial short stature:

GH deficiency:

Hypothyroidism:

SHOX gene haploinsufficiency / Leri-Weill dyschondrosteosis:

Skeletal dysplasias (achondroplasia, hypochondroplasia):

Chronic disease–related growth failure:

Premature ovarian insufficiency (POI) of other causes:

Klinefelter syndrome (47,XXY):

Key distinction: Short girl with webbed neck → karyotype mandatory to separate TS from Noonan. Right-sided heart disease + normal karyotype = Noonan.

Board pearl: SHOX deletion explains the short stature and Madelung deformity in TS — same gene, different syndromes.

Key Differentials — Other-Category Causes

— Marfan syndrome: tall thin habitus, arachnodactyly, ectopia lentis, MVP, aortic root dilation; FBN1 mutation; autosomal dominant

— Loeys-Dietz syndrome: bifid uvula, hypertelorism, arterial tortuosity, aggressive aneurysms; TGFBR1/2 mutations

— Ehlers-Danlos vascular type: translucent skin, easy bruising, arterial rupture; COL3A1

— Familial thoracic aortic aneurysm: isolated

— Key differentiator from TS: these patients are typically tall with normal karyotype

— Sporadic bicuspid aortic valve (~1% of population) — most common congenital cardiac lesion overall

— Williams syndrome (supravalvular AS, elfin facies, hypercalcemia, intellectual disability) — 7q11.23 deletion, normal karyotype

— DiGeorge/22q11.2 deletion (conotruncal anomalies, hypocalcemia, immunodeficiency)

— Müllerian agenesis (MRKH): normal breast development, normal karyotype 46,XX, absent uterus, normal ovaries

— Androgen insensitivity syndrome (CAIS): 46,XY, female phenotype, absent uterus, blind vaginal pouch, breast development, no axillary/pubic hair

— Imperforate hymen / transverse vaginal septum: cyclic pelvic pain, hematocolpos

— Hypothalamic amenorrhea: low FSH/LH (vs. elevated in TS)

— Hyperprolactinemia / pituitary disease: low FSH/LH

— Milroy disease (hereditary lymphedema, FLT4 mutation) — normal karyotype

— Hennekam syndrome, generalized lymphatic anomaly

— Noonan, Klippel-Feil, multiple pterygium syndrome

— Cleft palate sequelae, immunodeficiency, ciliary dyskinesia

Aortopathy mimics (when dissection or root dilation is the presenting issue):

Congenital heart disease causes of coarctation/bicuspid valve:

Primary amenorrhea — non-gonadal-dysgenesis causes:

Lymphedema differential in newborn:

Webbed neck differential:

Recurrent otitis / hearing loss:

Key distinction: Elevated FSH/LH (hypergonadotropic) + short stature = TS until karyotype proven otherwise. Elevated FSH/LH + normal stature = think Swyer (46,XY), 46,XX gonadal dysgenesis, or POI (autoimmune, FMR1, iatrogenic).

Board pearl: In MRKH and CAIS, FSH/LH are not elevated and stature is normal — that separates them cleanly from TS.

Secondary Prevention and Long-Term Plan

— BP target <130/80 (some advocate <120/80 if aortopathy); ACEi/ARB or beta-blocker preferred

— Statin per ASCVD risk calculator; lower threshold given premature CAD risk

— Aspirin only per standard primary/secondary prevention guidelines — not routine

— Endocarditis prophylaxis only for standard high-risk indications (prosthetic valve, prior IE, repaired CHD with residua) — not all TS patients

— Continue estrogen + cyclic progestin until ~age 50 (average menopause age)

— Transdermal estradiol preferred over oral

— Annual review of dose, symptoms, side effects, breast/pelvic exams

— Calcium 1000–1200 mg/day, vitamin D ≥800–1000 IU/day

— Weight-bearing exercise

— DXA every 2–5 years in adulthood

— Bisphosphonates if osteoporosis with fragility fracture

— Annual TSH (anti-TPO if not previously checked)

— TTG-IgA every 2–5 years or with symptoms

— Annual screen for diabetes (fasting glucose, A1c), lipids

— Levothyroxine (if hypothyroid)

— HRT (transdermal estradiol + cyclic progestin)

— Antihypertensive (ACEi/ARB or beta-blocker if needed)

— Statin if indicated

— Calcium + vitamin D

— rhGH in pediatric/adolescent years

— Standard pediatric/adult schedule; HPV per ACIP; influenza annually; pneumococcal per asplenic-like indications not routine in TS

— Weight management — metabolic risk is elevated

— Avoid smoking, limit alcohol

— Counsel against pregnancy if ASI/risk factors prohibit; effective contraception during fertile periods

Cardiovascular secondary prevention (highest priority):

Hormone replacement:

Bone health:

Autoimmune surveillance:

Discharge / long-term medication checklist:

Vaccinations:

Lifestyle:

Step 3 management: At every annual visit, your TS-specific "to-order" list is BP check, TSH, A1c, lipids, LFTs, urinalysis, weight/BMI, mood screen, and ask about hearing/vision — plus periodic echo/CMR.

Board pearl: Stopping HRT before age 50 in TS is harmful — bone and cardiovascular morbidity climb sharply.

Follow-Up, Monitoring Parameters, and Counseling

— Echocardiogram at diagnosis, then every 3–5 years if normal

— Cardiac MRI at least once at transition (~age 12 if cooperative or by adulthood); repeat every 5–10 years if stable

— Annual echo/CMR if aortic root dilated, hypertension, bicuspid valve, or post-coarctation repair

— Preconception and each trimester during pregnancy + 6 weeks postpartum

— Pediatric: growth velocity, weight, Tanner staging every 4–6 months on GH; IGF-1 every 6–12 months

— Annual TSH, fasting glucose/A1c, lipids, LFTs, urinalysis, BP, vitamin D

— TTG-IgA every 2–5 years

— Baseline at diagnosis; every 3–5 years in childhood; annually in adults due to progressive sensorineural loss

— At diagnosis; routine afterward unless abnormalities

— Early dental evaluation; orthodontics commonly needed (high-arched palate, crowding)

— DXA in late adolescence/adulthood after HRT established; repeat every 2–5 years

— Formal eval at school entry, late elementary, and high school transition; 504 plan or IEP for math/visuospatial supports

— Screen for anxiety, depression, body image, social functioning at every visit

— Peer support: Turner Syndrome Society, summer camps

— Childhood: disclosure of diagnosis in developmentally appropriate stages by age 8–12; involve patient in decisions

— Adolescence: sexuality, contraception (yes — mosaics can conceive), HRT adherence, body image, transition planning

— Adulthood: fertility options (donor oocyte IVF, adoption), pregnancy risks, cardiovascular surveillance, HRT continuation

— Begin at age 14, structured handoff to adult providers by age 18–21, written transition summary including karyotype, imaging, HRT, comorbidities, surveillance plan

Cardiac surveillance schedule:

Endocrine and metabolic monitoring:

Audiology:

Ophthalmology:

Dental:

Bone density:

Neuropsychological/educational:

Psychosocial:

Counseling topics by age:

Transition of care:

CCS pearl: "Schedule follow-up in 6 months" is rarely enough — for TS, schedule annual labs (TSH, A1c, lipids, LFTs, UA, BP) and echo every 3–5 years explicitly on the CCS.

Board pearl: Transition-of-care failures are a tested theme — TS patients lost to follow-up develop preventable aortic dissection.

Ethical, Legal, and Patient Safety Considerations

— Children should be informed of their TS diagnosis in developmentally appropriate stages, beginning by age 8–12, with full disclosure by adolescence

— Withholding from an adolescent patient is not ethically supported — undermines autonomy and adherence to HRT and surveillance

— Use trained genetic counselors; involve the patient in decisions about fertility, gonadectomy, HRT

— Prophylactic gonadectomy for Y-material — discuss alternatives, surveillance limitations, cancer risk, hormonal consequences; obtain parental consent and adolescent assent when age-appropriate

— Fertility preservation in minors — assent required; parents consent; document discussion of experimental nature of pediatric oocyte cryopreservation

— Growth hormone — informed consent should cover modest height gain (5–8 cm), cost, daily injections, side effects, and that GH does not treat ovarian failure

— NIPT-suggested monosomy X must be confirmed by diagnostic testing before any irreversible decisions — high false-positive rate

— Counseling should be nondirective, emphasizing variability of phenotype and modern outcomes; avoid biased framing

— Adults with TS have a right to pursue pregnancy after full disclosure of maternal mortality risk (~2% dissection); document the conversation

— Providers may decline to participate in donor oocyte IVF if aortic risk is prohibitive — refer for second opinion; do not coerce

— Sharing diagnosis with schools requires parental and (when appropriate) patient consent; protect against stigma

— Standard child safeguarding applies; no TS-specific reporting laws

— Medical alert bracelet advised — alerting EMS/anesthesia to bicuspid valve, aortopathy, difficult airway is a patient safety priority

— Pediatric-to-adult transition gaps cause loss to follow-up → missed aortic dilation → preventable dissection

— Use a structured transition checklist and a shared written summary; confirm first adult appointment is scheduled before discharging from pediatric care

— GH and HRT are costly — engage social work, prior authorization, manufacturer assistance programs

Disclosure of diagnosis:

Informed consent edge cases:

Prenatal counseling:

Reproductive autonomy:

Confidentiality and school:

Mandatory reporting and safety:

Transition-of-care risk (Step 3 favorite):

Health systems and access:

Step 3 management: Document the risk-of-pregnancy conversation in TS patients of reproductive age and provide effective contraception until a preconception cardiac evaluation is complete — this is both ethically and medicolegally protective.

Board pearl: A 16-year-old with TS asking about her diagnosis deserves a direct, complete, developmentally appropriate explanation — deferral "until she's older" is not the right answer.

High-Yield Associations and Rapid-Fire Clinical Facts

— 45,X most common (~45%); mosaicism ~30%; isochromosome Xq ~15%

— 45,X/46,XY → gonadectomy for gonadoblastoma risk

— Most 45,X conceptuses spontaneously abort (>99%)

— Short stature (~95%) — most consistent finding

— Ovarian failure (~90%) — streak gonads

— Webbed neck, low hairline, cubitus valgus, shield chest, short 4th metacarpal, lymphedema

— Bicuspid aortic valve ~30% (most common)

— Coarctation of aorta ~10–15%

— Aortic root dilation, dissection risk — index to BSA (ASI)

— Partial anomalous pulmonary venous return ~15% (CMR finds it)

— Prolonged QT — caution with QT-prolonging drugs

— rhGH starting ~age 4–6 (or earlier); ~0.375 mg/kg/week

— Transdermal estradiol starting ~age 11–12; add progestin after 2 years

— HRT until age ~50

— Donor oocyte IVF most common path

— ~2% maternal mortality from aortic dissection

— Preconception echo + CMR

— TS is sporadic; recurrence risk not increased

— NIPT for monosomy X has high false-positive rate — confirm with diagnostic karyotype

— Life expectancy reduced ~10–13 years; cardiovascular disease is the leading cause

— "Short girl, webbed neck, coarctation" → TS

— "Short girl, pulmonic stenosis" → Noonan

— "Tall, ectopia lentis, aortic root" → Marfan

— "Tall male, gynecomastia, small testes" → Klinefelter

Karyotype facts:

Phenotype quick hits:

Cardiac:

Renal: horseshoe kidney (~15–30%), duplicated collecting system

Endocrine: Hashimoto thyroiditis (~30%), T2DM, dyslipidemia, osteoporosis

GI: celiac disease (~5–8%), IBD, hepatic enzyme elevation, intestinal telangiectasias

ENT: chronic OM, conductive then sensorineural hearing loss

Neurocognitive: normal verbal IQ, weak nonverbal/math; ADHD, anxiety

SHOX gene: on Xp22.33, haploinsufficiency drives short stature and Madelung deformity

Treatment one-liners:

Pregnancy:

Genetic counseling pearls:

Mortality:

Common board buzzwords:

Board pearl: Coarctation in a girl + delayed puberty = karyotype today.

Board Question Stem Patterns

— "Newborn girl with lymphedema of hands and feet, redundant nuchal skin, and a continuous murmur. Femoral pulses are weak."

— Answer: Karyotype → echo for coarctation + bicuspid valve

— "8-year-old girl falling off growth curve, recurrent otitis media, short 4th metacarpal, cubitus valgus."

— Answer: Peripheral blood karyotype (≥30 cells); begin rhGH

— "14-year-old with no breast development, primary amenorrhea, FSH 95, LH 40, low estradiol, height 4'8"."

— Answer: Karyotype; initiate low-dose transdermal estradiol when diagnosis confirmed

— "26-year-old, 4'10", with history of coarctation repair, presents with tearing interscapular pain, BP 90/60 in right arm, 140/80 in left, mediastinal widening on CXR."

— Answer: CT angiography + IV esmolol/labetalol + CT surgery consult — aortic dissection

— "24-year-old TS patient wants to pursue donor oocyte IVF. Echo shows aortic root z-score +2.1."

— Answer: Obtain cardiac MRI, optimize BP, MFM consult; counsel on 2% dissection mortality; single-embryo transfer; consider deferral if ASI worsens

— "Phenotypically female adolescent with TS features; karyotype shows 45,X/46,XY."

— Answer: Prophylactic bilateral gonadectomy — gonadoblastoma risk

— "Short boy with webbed neck, pulmonary valve stenosis, normal karyotype, family history."

— Answer: Noonan syndrome, not TS — test for PTPN11

— "16-year-old with TS, fatigue, weight gain, constipation, dry skin."

— Answer: TSH — Hashimoto hypothyroidism

— "Pregnant woman, NIPT shows monosomy X. Next step?"

— Answer: Confirmatory amniocentesis with karyotype before counseling about pregnancy decisions

— "Young adult TS patient lost to follow-up since age 18, now presents with new aortic regurgitation murmur."

— Answer: Echo + cardiac MRI, reinitiate HRT, comprehensive Turner annual bundle

Stem pattern 1 — Newborn presentation:

Stem pattern 2 — Short child:

Stem pattern 3 — Delayed puberty:

Stem pattern 4 — Adult with chest pain:

Stem pattern 5 — Pregnancy planning:

Stem pattern 6 — Karyotype variant:

Stem pattern 7 — Mimic discrimination:

Stem pattern 8 — Comorbidity screen:

Stem pattern 9 — NIPT counseling:

Stem pattern 10 — Transition gap:

Board pearl: When the vignette gives you a short girl with elevated FSH, the answer is karyotype — even before any other test.

One-Line Recap

Turner syndrome is complete or partial absence of the second X chromosome in a phenotypic female, causing short stature, ovarian failure, and a high lifetime risk of left-sided cardiac disease and aortic dissection — diagnosed by karyotype and managed lifelong with growth hormone in childhood, transdermal estrogen-progestin replacement from adolescence through age 50, and aggressive cardiovascular and autoimmune surveillance.

Diagnostic anchor: Phenotypic female with unexplained short stature, primary amenorrhea with elevated FSH, or left-sided congenital heart disease → peripheral blood karyotype with ≥30 cells; if negative but suspicion persists, second-tissue karyotype or FISH; any Y-material → prophylactic gonadectomy.

The "Turner bundle" at diagnosis: karyotype confirmation, echocardiogram + eventual cardiac MRI, renal ultrasound, TSH, TTG-IgA, A1c, lipids, LFTs, FSH/LH/estradiol/AMH, IGF-1, audiology, ophthalmology, neuropsych — plus multidisciplinary referral.

Three management pillars: (1) rhGH ~0.375 mg/kg/week starting age 4–6 to maximize height; (2) transdermal estradiol at age 11–12 with cyclic progestin added after 2 years, continued until age ~50; (3) lifelong cardiovascular surveillance with aortic dimensions indexed to BSA (ASI) — dissection occurs at smaller diameters than in the general population.

High-stakes pitfalls: missing coarctation in a short girl, stopping HRT before age 50, allowing pregnancy without preconception echo + CMR + MFM clearance, failing to gonadectomize when Y-material is present, and losing patients during pediatric-to-adult transition of care — the leading preventable cause of late aortic dissection in TS.

Board pearl: Short stature + delayed puberty + elevated FSH = Turner syndrome until karyotype proves otherwise — and karyotype is the answer before any other test.